Skip to main content
Erschienen in: World Journal of Surgery 3/2019

21.11.2018 | Original Scientific Report

Bone Mineral Density as a Risk Factor for Patients Undergoing Surgery for Hepatocellular Carcinoma

verfasst von: Yosuke Miyachi, Toshimi Kaido, Siuan Yao, Hisaya Shirai, Atsushi Kobayashi, Yuhei Hamaguchi, Naoko Kamo, Shintaro Yagi, Shinji Uemoto

Erschienen in: World Journal of Surgery | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

We have reported the impact of sarcopenia and body composition on patients undergoing hepatectomy for hepatocellular carcinoma (HCC). However, the impact of bone mineral density (BMD) on outcomes after hepatectomy for HCC and correlation with other parameters including sarcopenia are unclear.

Methods

We retrospectively analyzed 465 patients who underwent primary hepatectomy for HCC between April 2005 and March 2015. We analyzed the plain CT images at the level of the eleventh thoracic vertebra with the region of interest and defined as preoperative BMD.

Results

In this cohort, male (n = 367) and female (n = 98) patients showed significant heterogeneity in age, body composition markers, tumor factors, peri-operative parameters and so on. The median preoperative BMD in male and female patients was 155 and 139 HU, respectively (P = 0.005). BMD was negatively correlated with age in female (r = −0.590, P < 0.001) and intramuscular adipose tissue content in both male and female (r = −0.332 and −0.359, respectively, P < 0.001). For males, BMD < 160 HU was associated with worse cancer-specific survival post-hepatectomy (P = 0.015). In contrast, females were not (P = 0.135). For male patients, multivariate analysis identified low BMD as an independent risk factor for death (hazard ratio 1.720, 95% confidence interval 1.038–2.922, P = 0.035) after hepatectomy for HCC.

Conclusion

Preoperative low BMD was an independent risk factor for cancer-specific mortality after hepatectomy for HCC.
Literatur
1.
Zurück zum Zitat Fong ZV, Tanabe KK (2014) The clinical management of hepatocellular carcinoma in the United States, Europe, and Asia: a comprehensive and evidence-based comparison and review. Cancer 120:2824–2838CrossRefPubMed Fong ZV, Tanabe KK (2014) The clinical management of hepatocellular carcinoma in the United States, Europe, and Asia: a comprehensive and evidence-based comparison and review. Cancer 120:2824–2838CrossRefPubMed
2.
Zurück zum Zitat Cucchetti A, Piscaglia F, Pinna AD et al (2017) Efficacy and safety of systemic therapies for advanced hepatocellular carcinoma: a network meta-analysis of phase III trials. Liver Cancer 6:337–348CrossRefPubMedPubMedCentral Cucchetti A, Piscaglia F, Pinna AD et al (2017) Efficacy and safety of systemic therapies for advanced hepatocellular carcinoma: a network meta-analysis of phase III trials. Liver Cancer 6:337–348CrossRefPubMedPubMedCentral
3.
4.
Zurück zum Zitat Berzigotti A, Reig M, Abraldes JG et al (2015) Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: a systematic review and meta-analysis. Hepatology 61:526–536CrossRefPubMed Berzigotti A, Reig M, Abraldes JG et al (2015) Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: a systematic review and meta-analysis. Hepatology 61:526–536CrossRefPubMed
5.
Zurück zum Zitat Cabibbo G, Enea M, Attanasio M et al (2010) A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma. Hepatology 51:1274–1283CrossRefPubMed Cabibbo G, Enea M, Attanasio M et al (2010) A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma. Hepatology 51:1274–1283CrossRefPubMed
6.
Zurück zum Zitat Lise M, Bacchetti S, Da Pian P et al (1998) Prognostic factors affecting long term outcome after liver resection for hepatocellular carcinoma: results in a series of 100 Italian patients. Cancer 82:1028–1036CrossRefPubMed Lise M, Bacchetti S, Da Pian P et al (1998) Prognostic factors affecting long term outcome after liver resection for hepatocellular carcinoma: results in a series of 100 Italian patients. Cancer 82:1028–1036CrossRefPubMed
7.
Zurück zum Zitat Llovet JM, Bustamante J, Castells A et al (1999) Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology 29:62–67CrossRefPubMed Llovet JM, Bustamante J, Castells A et al (1999) Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology 29:62–67CrossRefPubMed
8.
Zurück zum Zitat Okuda K, Ohtsuki T, Obata H et al (1985) Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer 56:918–928CrossRefPubMed Okuda K, Ohtsuki T, Obata H et al (1985) Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer 56:918–928CrossRefPubMed
9.
Zurück zum Zitat Costentin CE, Ferrone CR, Arellano RS et al (2017) Hepatocellular carcinoma with macrovascular invasion: defining the optimal treatment strategy. Liver Cancer 6:360–374CrossRefPubMedPubMedCentral Costentin CE, Ferrone CR, Arellano RS et al (2017) Hepatocellular carcinoma with macrovascular invasion: defining the optimal treatment strategy. Liver Cancer 6:360–374CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Chok KS, Ng KK, Poon RT et al (2009) Impact of postoperative complications on long-term outcome of curative resection for hepatocellular carcinoma. Br J Surg 96:81–87CrossRefPubMed Chok KS, Ng KK, Poon RT et al (2009) Impact of postoperative complications on long-term outcome of curative resection for hepatocellular carcinoma. Br J Surg 96:81–87CrossRefPubMed
11.
Zurück zum Zitat Hidaka M, Takatsuki M, Soyama A et al (2012) Intraoperative portal venous pressure and long-term outcome after curative resection for hepatocellular carcinoma. Br J Surg 99:1284–1289CrossRefPubMed Hidaka M, Takatsuki M, Soyama A et al (2012) Intraoperative portal venous pressure and long-term outcome after curative resection for hepatocellular carcinoma. Br J Surg 99:1284–1289CrossRefPubMed
13.
Zurück zum Zitat Cruz-Jentoft AJ, Baeyens JP, Bauer JM et al (2010) Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people. Age Ageing 39:412–423CrossRefPubMedPubMedCentral Cruz-Jentoft AJ, Baeyens JP, Bauer JM et al (2010) Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people. Age Ageing 39:412–423CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Fujiwara N, Nakagawa H, Kudo Y et al (2015) Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma. J Hepatol 63:131–140CrossRefPubMed Fujiwara N, Nakagawa H, Kudo Y et al (2015) Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma. J Hepatol 63:131–140CrossRefPubMed
16.
Zurück zum Zitat Valero V 3rd, Amini N, Spolverato G et al (2015) Sarcopenia adversely impacts postoperative complications following resection or transplantation in patients with primary liver tumors. J Gastrointest Surg 19:272–281CrossRefPubMed Valero V 3rd, Amini N, Spolverato G et al (2015) Sarcopenia adversely impacts postoperative complications following resection or transplantation in patients with primary liver tumors. J Gastrointest Surg 19:272–281CrossRefPubMed
17.
Zurück zum Zitat Voron T, Tselikas L, Pietrasz D et al (2015) Sarcopenia impacts on short- and long-term results of hepatectomy for hepatocellular carcinoma. Ann Surg 261:1173–1183CrossRefPubMed Voron T, Tselikas L, Pietrasz D et al (2015) Sarcopenia impacts on short- and long-term results of hepatectomy for hepatocellular carcinoma. Ann Surg 261:1173–1183CrossRefPubMed
18.
Zurück zum Zitat Hamaguchi Y, Kaido T, Okumura S et al (2014) Impact of quality as well as quantity of skeletal muscle on outcomes after liver transplantation. Liver Transpl 20:1413–1419CrossRefPubMed Hamaguchi Y, Kaido T, Okumura S et al (2014) Impact of quality as well as quantity of skeletal muscle on outcomes after liver transplantation. Liver Transpl 20:1413–1419CrossRefPubMed
19.
Zurück zum Zitat Hamaguchi Y, Kaido T, Okumura S et al (2015) Preoperative intramuscular adipose tissue content is a novel prognostic predictor after hepatectomy for hepatocellular carcinoma. J Hepatobiliary Pancreat Sci 22:475–485CrossRefPubMed Hamaguchi Y, Kaido T, Okumura S et al (2015) Preoperative intramuscular adipose tissue content is a novel prognostic predictor after hepatectomy for hepatocellular carcinoma. J Hepatobiliary Pancreat Sci 22:475–485CrossRefPubMed
21.
Zurück zum Zitat Okumura S, Kaido T, Hamaguchi Y et al (2015) Impact of preoperative quality as well as quantity of skeletal muscle on survival after resection of pancreatic cancer. Surgery 157:1088–1098CrossRefPubMed Okumura S, Kaido T, Hamaguchi Y et al (2015) Impact of preoperative quality as well as quantity of skeletal muscle on survival after resection of pancreatic cancer. Surgery 157:1088–1098CrossRefPubMed
22.
Zurück zum Zitat Okumura S, Kaido T, Hamaguchi Y et al (2016) Impact of the preoperative quantity and quality of skeletal muscle on outcomes after resection of extrahepatic biliary malignancies. Surgery 159:821–833CrossRefPubMed Okumura S, Kaido T, Hamaguchi Y et al (2016) Impact of the preoperative quantity and quality of skeletal muscle on outcomes after resection of extrahepatic biliary malignancies. Surgery 159:821–833CrossRefPubMed
24.
Zurück zum Zitat Kanis JA (2002) Diagnosis of osteoporosis and assessment of fracture risk. Lancet (Lond) 359:1929–1936CrossRef Kanis JA (2002) Diagnosis of osteoporosis and assessment of fracture risk. Lancet (Lond) 359:1929–1936CrossRef
25.
Zurück zum Zitat Kanis JA, McCloskey EV, Johansson H et al (2013) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 24:23–57CrossRefPubMed Kanis JA, McCloskey EV, Johansson H et al (2013) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 24:23–57CrossRefPubMed
26.
Zurück zum Zitat Sharma P, Parikh ND, Yu J et al (2016) Bone mineral density predicts posttransplant survival among hepatocellular carcinoma liver transplant recipients. Liver Transpl 22:1092–1098CrossRefPubMedPubMedCentral Sharma P, Parikh ND, Yu J et al (2016) Bone mineral density predicts posttransplant survival among hepatocellular carcinoma liver transplant recipients. Liver Transpl 22:1092–1098CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Pickhardt PJ, Pooler BD, Lauder T et al (2013) Opportunistic screening for osteoporosis using abdominal computed tomography scans obtained for other indications. Ann Intern Med 158:588–595CrossRefPubMedPubMedCentral Pickhardt PJ, Pooler BD, Lauder T et al (2013) Opportunistic screening for osteoporosis using abdominal computed tomography scans obtained for other indications. Ann Intern Med 158:588–595CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Verschueren S, Gielen E, O’Neill TW et al (2013) Sarcopenia and its relationship with bone mineral density in middle-aged and elderly European men. Osteoporos Int 24:87–98CrossRefPubMed Verschueren S, Gielen E, O’Neill TW et al (2013) Sarcopenia and its relationship with bone mineral density in middle-aged and elderly European men. Osteoporos Int 24:87–98CrossRefPubMed
29.
Zurück zum Zitat Lee S, Chung CK, Oh SH et al (2013) Correlation between bone mineral density measured by dual-energy X-ray absorptiometry and hounsfield units measured by diagnostic CT in lumbar spine. J Korean Neurosurg Soc 54:384–389CrossRefPubMedPubMedCentral Lee S, Chung CK, Oh SH et al (2013) Correlation between bone mineral density measured by dual-energy X-ray absorptiometry and hounsfield units measured by diagnostic CT in lumbar spine. J Korean Neurosurg Soc 54:384–389CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Samelson EJ, Christiansen BA, Demissie S et al (2012) QCT measures of bone strength at the thoracic and lumbar spine: the Framingham study. J Bone Miner Res 27:654–663CrossRefPubMed Samelson EJ, Christiansen BA, Demissie S et al (2012) QCT measures of bone strength at the thoracic and lumbar spine: the Framingham study. J Bone Miner Res 27:654–663CrossRefPubMed
31.
Zurück zum Zitat Warming L, Hassager C, Christiansen C (2002) Changes in bone mineral density with age in men and women: a longitudinal study. Osteoporos Int 13:105–112CrossRefPubMed Warming L, Hassager C, Christiansen C (2002) Changes in bone mineral density with age in men and women: a longitudinal study. Osteoporos Int 13:105–112CrossRefPubMed
32.
Zurück zum Zitat Pereira FB, Leite AF, de Paula AP (2015) Relationship between pre-sarcopenia, sarcopenia and bone mineral density in elderly men. Arch Endocrinol Metab 59:59–65CrossRefPubMed Pereira FB, Leite AF, de Paula AP (2015) Relationship between pre-sarcopenia, sarcopenia and bone mineral density in elderly men. Arch Endocrinol Metab 59:59–65CrossRefPubMed
33.
Zurück zum Zitat Li H, Hong S, Qian J et al (2010) Cross talk between the bone and immune systems: osteoclasts function as antigen-presenting cells and activate CD4+ and CD8+ T cells. Blood 116:210–217CrossRefPubMedPubMedCentral Li H, Hong S, Qian J et al (2010) Cross talk between the bone and immune systems: osteoclasts function as antigen-presenting cells and activate CD4+ and CD8+ T cells. Blood 116:210–217CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Takayanagi H (2007) Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat Rev Immunol 7:292–304CrossRefPubMed Takayanagi H (2007) Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat Rev Immunol 7:292–304CrossRefPubMed
36.
Zurück zum Zitat Tonti E, Jimenez de Oya N, Galliverti G et al (2013) Bisphosphonates target B cells to enhance humoral immune responses. Cell Rep 5:323–330CrossRefPubMed Tonti E, Jimenez de Oya N, Galliverti G et al (2013) Bisphosphonates target B cells to enhance humoral immune responses. Cell Rep 5:323–330CrossRefPubMed
37.
Zurück zum Zitat Honda Y, Takahashi S, Zhang Y et al (2015) Effects of bisphosphonate zoledronic acid in hepatocellular carcinoma, depending on mevalonate pathway. J Gastroenterol Hepatol 30:619–627CrossRefPubMed Honda Y, Takahashi S, Zhang Y et al (2015) Effects of bisphosphonate zoledronic acid in hepatocellular carcinoma, depending on mevalonate pathway. J Gastroenterol Hepatol 30:619–627CrossRefPubMed
38.
Zurück zum Zitat Bolam KA, van Uffelen JG, Taaffe DR (2013) The effect of physical exercise on bone density in middle-aged and older men: a systematic review. Osteoporos Int 24:2749–2762CrossRefPubMed Bolam KA, van Uffelen JG, Taaffe DR (2013) The effect of physical exercise on bone density in middle-aged and older men: a systematic review. Osteoporos Int 24:2749–2762CrossRefPubMed
40.
Zurück zum Zitat Edwards BJ, Bunta AD, Lane J et al (2013) Bisphosphonates and nonhealing femoral fractures: analysis of the FDA adverse event reporting system (FAERS) and international safety efforts. J Bone Joint Surg-Am 95:297–307CrossRefPubMedPubMedCentral Edwards BJ, Bunta AD, Lane J et al (2013) Bisphosphonates and nonhealing femoral fractures: analysis of the FDA adverse event reporting system (FAERS) and international safety efforts. J Bone Joint Surg-Am 95:297–307CrossRefPubMedPubMedCentral
Metadaten
Titel
Bone Mineral Density as a Risk Factor for Patients Undergoing Surgery for Hepatocellular Carcinoma
verfasst von
Yosuke Miyachi
Toshimi Kaido
Siuan Yao
Hisaya Shirai
Atsushi Kobayashi
Yuhei Hamaguchi
Naoko Kamo
Shintaro Yagi
Shinji Uemoto
Publikationsdatum
21.11.2018
Verlag
Springer International Publishing
Erschienen in
World Journal of Surgery / Ausgabe 3/2019
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-018-4861-x

Weitere Artikel der Ausgabe 3/2019

World Journal of Surgery 3/2019 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.